(Q48384855)

11 February 2018

http://europepmc.org/abstract/MED/9756147

title

Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease (English)

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

0 references

1 reference

Ryoo HL

1

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

Pierrotti D

series ordinal

2

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

Joyce JN

series ordinal

3

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

language of work or name

English

0 references

publication date

1 September 1998

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

published in

Movement Disorders

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

volume

13

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

issue

5

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

page(s)

788-797

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

cites work

Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.870130506

Pharmacologic profile of ropinirole: a nonergoline dopamine agonist

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FMDS.870130506

21 January 2018

Identifiers

DOI

10.1002/MDS.870130506

1 reference

11 February 2018

http://europepmc.org/abstract/MED/9756147

1 reference

11 February 2018